(1)
Disclosure Statement.
(a) All carriers offering either accelerated
benefit products or waiver of surrender charges for early withdrawals of
annuity proceeds, shall issue a disclosure statement, as
describedin211
CMR 55.100, to the applicant at the time
application is made or by separate communication with receipt or certification
of delivery. The disclosure statement must be a free-standing document, plainly
printed in light-faced type of a style in general use, the size of which shall
be uniform and not less than 12-point type with boldface type as noted, and
must not contain material of an advertising nature. The disclosure statement
must be signed by the owner or proposed owner of the policy, as well as the
writing insurance producer or company representative at the time of
application.
(b) All carriers
offering either accelerated benefit products or waiver of surrender charges for
early withdrawals of annuity proceeds shall issue the appropriate disclosure
statement, as described in
211
CMR 55.110, to the applicant at the time
application for accelerated benefits or early withdrawal with waiver of
surrender charges is elected or by separate communication with receipt or
certification of delivery. All terms used must be clearly explained so that the
policyholder understands the effect of accelerating death benefits or making an
early withdrawal on annuity proceeds.
(c) For policies that do not provide benefits
in the case of Chronic Illness, carriers may omit from the disclosure statement
all references to Chronic Illness.
(2)
Additional Disclosures for
Accelerated Benefit Products. In addition to the requirements of
211 CMR 55.06(1), it shall be considered an unfair and deceptive practice if a
carrier fails to meet the following requirements:
(a) All terms used in the policy must be
fully explained so that the policyholder or certificateholder understands his
or her relationship to the benefits provided;
(b) No misleading policy names may be
used;
(c) The term "accelerated
benefit" shall be included in the description, and the term "long-term care
insurance" may not be used in describing or marketing accelerated benefit
products;
(d) Limitations or
exclusions must be highlighted on the first page of the policy, or there must
be a highlighted cross-reference onthe first page to the "limitations or
exclusions" section of the policy;
(e) If a policy is convertible, a notice is
to be on the first page that identifies that the policy is
convertible;
(f) If issued on other
than an individual basis, policies providing conversion privileges must specify
the benefits to be provided or must state that the converted coverage shall be
on the policy form then being issued by the company for this purpose;
(g) When age is to be used as a determining
factor for reducing the benefits made available in the policy as originally
issued, such fact must be prominently set forth in the policy;
(h) If the policy is issued on a basis other
than that applied for, a disclosure statement properly describing the policy
must accompany the policy when it is delivered and contain the following
statement, in no less than 14-point type, immediately above the company name:
"NOTICE: Read this disclosure statement carefully. The coverage you originally
applied for has not been issued. This policy is therefore not identical to the
coverage you requested - it differs in the following respects:
[list];"
(i) Riders or endorsements
that provide a benefit for which a specific premium is charged must show the
premium on the application, rider, or elsewhere in the policy;
(j) Any rider that reduces benefits requires
a signed acceptance by the policyholder or certificateholder unless such
coverage is provided under a master policy owned by an employer or trade
union;
(k) Prior to the addition of
an accelerated benefit product to anexisting life insurance policy and prior to
the payment of any accelerated benefit to the policyholder or non-group policy
owner, the carrier shall notify any assignee or irrevocable beneficiary in
writing, at his or her last known address, of any present or future effect on
the rights of such third parties under the life insurance policy, and may
require a signed acknowledgment of concurrence before paying accelerated
benefits;
(l) The carrier must
prominently note the following, in substantially similar form and content, on
either the face of the policy or rider, or on a sticker attached to the face of
the policy or rider: "Accelerated benefit payments from this policy may qualify
for special tax status, if, according to federal definitions, the insured
qualifies as terminally ill, or qualifies as chronically ill and uses the
accelerated benefit to pay for costs incurred by the insured for qualified
long-term care services provided for the insured during the chronic illness.
However, ifthe accelerated benefit is based on "medical conditions" and not
terminal or chronic illness as defined in the federal tax code, the benefits
maybe taxable. We recommend that you contact a tax advisor
whenmakingtax-related decisions about electing to receive and use benefits from
an accelerated benefit product."
(3)
Additional Disclosure
Required at Time of Claim for Accelerated Benefits.
(a) The carrier must prominently note the
following, in substantially similar form and content, on either the face of the
claim settlement, or on a sticker attached to the face of the settlement of a
claim for accelerated benefits: "Accelerated benefit payments from this policy
may qualify for special tax status, if, according to federal definitions, the
insured qualifies as terminally ill, or qualifies as chronicallyill and uses
the accelerated benefit to pay for costs incurred by the insured for qualified
long-term care insurance services provided for the insured during the chronic
illness. However, if the accelerated benefit is based on "medical conditions"
and not terminal or chronic illness as defined in the federal tax code, the
benefits may be taxable. We recommend that you contact a tax advisor when
making tax-related decisions about electing to receive and use benefits from an
accelerated benefit product."
(b)
The carrier must provide an illustration as set forth in
211
CMR 55.110, or one which contains
substantially the same information in a format approved by the
Commissioner.
(c)
Lump
Sum Payments: Regardless of the marketing method used, when a
policyholder makes a claim for the lump sum payment of accelerated benefits for
policies other than those providing benefits for conditions of Chronic Illness
only and those policies using the lien method described in
211 CMR
55.05(10)(b), the carrier is
required to issue a new or amended schedule page to reflect any new, reduced
in-force face amount of the underlying life insurance policy, and any effect on
the accumulation account, cash value, loan balance and future premiums. Group
carriers paying such claims may substitute an equivalent Explanation of
Benefits statement for delivery to the group certificateholder.
(4)
Periodic Payment
Statement: If the accelerated benefit is paid in periodic payments
instead of a lump sum, and the policy's underlying contract values change with
each payment, each time an accelerated benefit payment is made, the carrier is
required to send to the policyholder a statement containing the underlying
contract values.